• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前红细胞分布宽度和中性粒细胞与淋巴细胞比值可预测上皮性卵巢癌患者的生存情况。

Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer.

机构信息

Department of Gynecologic Oncology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Tumor Hospital), 519 Kunzhou Road, Kunming 650118, China.

Department of Health Sciences Research, Mayo Clinic, Rochester 55905, USA.

出版信息

Sci Rep. 2017 Feb 22;7:43001. doi: 10.1038/srep43001.

DOI:10.1038/srep43001
PMID:28223716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5320446/
Abstract

Several parameters of preoperative complete blood count (CBC) and inflammation-associated blood cell markers derived from them have been reported to correlate with prognosis in patients with epithelial ovarian cancer (EOC), but their prognostic importance and optimal cutoffs are still needed be elucidated. Clinic/pathological parameters, 5-year follow-up data and preoperative CBC parameters were obtained retrospectively in 654 EOC patients underwent primary surgery at Mayo Clinic. Cutoffs for neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) were optimized by receiver operating characteristic (ROC) curve. Prognostic significance for overall survival (OS) and recurrence free survival (RFS) were determined by Cox proportional hazards models and Kaplan-Meier method. Associations of RDW and NLR with clinic/pathological parameters were analyzed using non-parametric tests. RDW with cutoff 14.5 and NLR with cutoff 5.25 had independent prognostic significance for OS, while combined RDW and NLR scores stratified patients into low (RDW-low and NLR-low), intermediate (RDW-high or NLR-high) and high risk (RDW-high and NLR-high) groups, especially in patients with high-grade serous ovarian cancer (HGSOC). Moreover, high NLR was associated with poor RFS as well. Elevated RDW was strongly associated with age, whereas high NLR was strongly associated with stage, preoperative CA125 level and ascites at surgery.

摘要

术前全血细胞计数(CBC)的几个参数和由此衍生的与炎症相关的血细胞标志物已被报道与上皮性卵巢癌(EOC)患者的预后相关,但它们的预后意义和最佳截断值仍需要阐明。在梅奥诊所接受初次手术的 654 名 EOC 患者中,回顾性地获得了临床/病理参数、5 年随访数据和术前 CBC 参数。通过接受者操作特征(ROC)曲线优化中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和单核细胞与淋巴细胞比值(MLR)的截断值。通过 Cox 比例风险模型和 Kaplan-Meier 方法确定总生存期(OS)和无复发生存期(RFS)的预后意义。使用非参数检验分析 RDW 和 NLR 与临床/病理参数的相关性。截断值为 14.5 的 RDW 和截断值为 5.25 的 NLR 对 OS 具有独立的预后意义,而联合 RDW 和 NLR 评分将患者分层为低(RDW-低和 NLR-低)、中(RDW-高或 NLR-高)和高风险(RDW-高和 NLR-高)组,特别是在高级别浆液性卵巢癌(HGSOC)患者中。此外,高 NLR 与较差的 RFS 相关。高 RDW 与年龄强烈相关,而高 NLR 与分期、术前 CA125 水平和手术时腹水强烈相关。

相似文献

1
Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer.术前红细胞分布宽度和中性粒细胞与淋巴细胞比值可预测上皮性卵巢癌患者的生存情况。
Sci Rep. 2017 Feb 22;7:43001. doi: 10.1038/srep43001.
2
Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.中性粒细胞与淋巴细胞比值及血小板计数可预测IIIC期上皮性卵巢癌的长期预后。
Cell Physiol Biochem. 2018;46(1):178-186. doi: 10.1159/000488420. Epub 2018 Mar 21.
3
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测接受铂类化疗的上皮性卵巢癌患者的化疗反应及预后。
Cancer Biomark. 2016 Jun 7;17(1):33-40. doi: 10.3233/CBM-160614.
4
Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.中性粒细胞计数和中性粒细胞与淋巴细胞比值在卵巢癌患者中的临床应用比较:单中心经验及文献复习。
Int J Clin Oncol. 2018 Feb;23(1):104-113. doi: 10.1007/s10147-017-1180-4. Epub 2017 Sep 26.
5
The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.治疗前中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及红细胞分布宽度可预测喉癌患者的预后。
Eur Arch Otorhinolaryngol. 2017 Jan;274(1):535-542. doi: 10.1007/s00405-016-4250-8. Epub 2016 Aug 12.
6
Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer.术前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在上皮性卵巢癌患者中的预后价值
Eur J Gynaecol Oncol. 2017;38(3):444-448.
7
Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer.中性粒细胞与淋巴细胞比值作为上皮性卵巢癌预后指标的作用。
J Med Assoc Thai. 2011 Jul;94(7):871-7.
8
Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值在可手术切除食管鳞状细胞癌中的预后作用
World J Gastroenterol. 2015 May 14;21(18):5591-7. doi: 10.3748/wjg.v21.i18.5591.
9
[The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].[术前淋巴细胞与单核细胞比值与上皮性卵巢癌患者临床病理特征及预后的关系]
Zhonghua Zhong Liu Za Zhi. 2017 Sep 23;39(9):676-680. doi: 10.3760/cma.j.issn.0253-3766.2017.09.007.
10
The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对四肢巨细胞瘤的预后意义。
BMC Cancer. 2019 Apr 8;19(1):329. doi: 10.1186/s12885-019-5511-x.

引用本文的文献

1
Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer.前列腺特异抗原密度(PSA density)与肌层浸润率(MLR)相结合可提高前列腺癌的诊断准确性。
Front Oncol. 2025 Jul 16;15:1570584. doi: 10.3389/fonc.2025.1570584. eCollection 2025.
2
Routine Blood Tests as Predictive Tools for Differentiating Follicular Thyroid Carcinoma From Follicular Adenoma.常规血液检查作为鉴别滤泡性甲状腺癌与滤泡性腺瘤的预测工具
Int J Gen Med. 2025 Feb 12;18:733-744. doi: 10.2147/IJGM.S502626. eCollection 2025.
3
Development and validation of a nomogram to predict recurrence in epithelial ovarian cancer using complete blood count and lipid profiles.

本文引用的文献

1
Neutrophils in the Tumor Microenvironment.肿瘤微环境中的中性粒细胞
Trends Immunol. 2016 Jan;37(1):41-52. doi: 10.1016/j.it.2015.11.008. Epub 2015 Dec 14.
2
Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells.从淋巴细胞与肿瘤细胞的相互作用预测预后和治疗反应。
Mol Oncol. 2015 Dec;9(10):2054-62. doi: 10.1016/j.molonc.2015.10.003. Epub 2015 Oct 23.
3
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.重新思考卵巢癌II:降低高级别浆液性卵巢癌的死亡率
利用全血细胞计数和血脂谱建立预测上皮性卵巢癌复发的列线图并进行验证。
Front Oncol. 2025 Feb 3;15:1525867. doi: 10.3389/fonc.2025.1525867. eCollection 2025.
4
The effect of preoperative laboratory values on prognostic factors following cytoreduction surgery in ovarian cancer: Neutrophil lymphocyte ratio, platelet lymphocyte ratio, and lymphocyte monocyte ratio.术前实验室检查值对卵巢癌肿瘤细胞减灭术后预后因素的影响:中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及淋巴细胞与单核细胞比值。
Medicine (Baltimore). 2025 Feb 14;104(7):e41504. doi: 10.1097/MD.0000000000041504.
5
The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer.循环免疫细胞和 CA125 动态变化对晚期卵巢癌新辅助治疗选择的影响。
Medicina (Kaunas). 2024 Aug 9;60(8):1290. doi: 10.3390/medicina60081290.
6
The prognostic and clinical value of neutrophil-to-lymphocyte ratio (NLR) in ovarian cancer: A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值(NLR)在卵巢癌中的预后及临床价值:一项系统评价和荟萃分析
J Med Biochem. 2024 Jun 15;43(4):323-333. doi: 10.5937/jomb0-46035.
7
Preoperative Immune Cell Dysregulation Accompanies Ovarian Cancer Patients into the Postoperative Period.术前免疫细胞失调伴随卵巢癌患者进入术后期。
Int J Mol Sci. 2024 Jun 28;25(13):7087. doi: 10.3390/ijms25137087.
8
Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line.一线治疗晚期卵巢癌患者的全血细胞计数获得的全身炎症反应指标的预后价值。
Clin Transl Oncol. 2024 Dec;26(12):3211-3217. doi: 10.1007/s12094-024-03523-3. Epub 2024 Jun 10.
9
The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及单核细胞与淋巴细胞比值(MLR)在子宫良性疾病与子宫内膜恶性肿瘤鉴别诊断中的预测价值
Discov Oncol. 2024 Mar 31;15(1):91. doi: 10.1007/s12672-024-00956-8.
10
Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值、血小板与淋巴细胞比值、C 反应蛋白和癌抗原 125 对卵巢癌的诊断作用。
J Int Med Res. 2023 Dec;51(12):3000605231218557. doi: 10.1177/03000605231218557.
Nat Rev Cancer. 2015 Nov;15(11):668-79. doi: 10.1038/nrc4019.
4
A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.单核细胞/粒细胞与淋巴细胞比值可预测肝细胞癌患者的生存率。
Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263.
5
Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer.上皮性卵巢癌长期存活者的特征
Obstet Gynecol. 2015 Sep;126(3):491-497. doi: 10.1097/AOG.0000000000000981.
6
The Prognostic Significance of Inflammation-Associated Blood Cell Markers in Patients with Upper Tract Urothelial Carcinoma.炎症相关血细胞标志物在上尿路尿路上皮癌患者中的预后意义
Ann Surg Oncol. 2016 Jan;23(1):343-51. doi: 10.1245/s10434-015-4781-z. Epub 2015 Aug 5.
7
Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.列线图预测纳入治疗前外周血标志物的小细胞肺癌患者的总生存。
J Thorac Oncol. 2015 Aug;10(8):1213-20. doi: 10.1097/JTO.0000000000000585.
8
Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour.结直肠癌中的全身中性粒细胞与淋巴细胞比值:与患者生存、肿瘤生物学及肿瘤局部淋巴细胞反应的关系
Br J Cancer. 2015 Jul 14;113(2):204-11. doi: 10.1038/bjc.2015.87. Epub 2015 Jun 30.
9
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.术前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测子宫内膜癌患者的生存率。
Br J Cancer. 2015 Jul 14;113(2):311-20. doi: 10.1038/bjc.2015.200. Epub 2015 Jun 16.
10
Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.与其他全身炎症反应标志物相比,术前血小板/淋巴细胞比值是卵巢癌患者更优的预后因素。
Tumour Biol. 2015 Nov;36(11):8831-7. doi: 10.1007/s13277-015-3533-9. Epub 2015 Jun 11.